Similar content being viewed by others Introduction GLP-1RAs are a class of pharmacological agents employed in managing two highly prevalent metabolic disorders worldwide: type 2 diabetes mellitus (T2DM) and obesity [1]
Your GP may arrange: Blood tests including full blood count, inflammatory markers (CRP, ESR), and specific infection screens Ultrasound imaging to characterise the lymph nodes and surrounding structures Fine needle aspiration or biopsy if there is concern about the nature of the swelling (excisional biopsy may be preferred if lymphoma is suspected) Referral to specialist services such as haematology, infectious diseases, or ear, nose, and throat (ENT) specialists NICE guidance emphasises the importance of thorough assessment of unexplained lymphadenopathy, with urgent referral (within two weeks) if features suggestive of malignancy are present
Tirzepatide: Does Your Injection Site Matter
Look for guidance grounded in evidence and qualified professionals.
Initially developed for type 2 diabetes, they are now recognized for their broad impact on weight regulation, inflammation, cardiovascular health, and neuroprotectiondomains central to longevity and healthy aging